Recalcitrant eumycetoma of the foot: Financial burden a major barrier on the road of recovery

PLoS Negl Trop Dis. 2020 Aug 6;14(8):e0008356. doi: 10.1371/journal.pntd.0008356. eCollection 2020 Aug.

Authors

Gagandeep Singh¹, Reshu Agarwal¹, Swati Khullar¹, Immaculata Xess¹, Vinod Kumar Sharma², Ankur Goyal³

Affiliations

¹ Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
² Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
³ Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Amputation, Surgical
Antifungal Agents / economics
Antifungal Agents / therapeutic use*
Cost of Illness*
Foot / microbiology
Foot / surgery
Humans
India
Male
Mycetoma / drug therapy*
Mycetoma / economics
Mycetoma / surgery
Patient Compliance
Treatment Outcome

Substances

Antifungal Agents

Grants and funding

The author(s) received no specific funding for this work.